Dr Barbara Fazekas

BSc., MSc., PhD



I completed my PhD at the Dermatology and Allergology, University of Szeged, Hungary. My PhD research focused on the UVB- and plasma radiation-induced cellular responses of human keratinocytes.
In 2016, I relocated to Ireland to undertake a Research Assistant position in the Renal Inflammation Group at Trinity College Dublin where I was involved in multiple projects, particularly in dissecting the pathogenesis of anti-PR3 vasculitis using humanised mice.
In 2017, I have received a Postdoctoral Fellowship under the Enterprise IRC Partnership Scheme with Prof. Matthew Griffin (Immunology, Regenerative Medicine Institute, NUI Galway) in collaboration with Dr Stephen Elliman (Orbsen Therapeutics Ltd) to study the therapeutic potential of mesenchymal stem/stromal cells (MSCs) in a common, severe sepsis-associated renal disease [acute kidney injury (AKI)].
In 2019, I joined Prof. John Dalton’s group (Dalton Laboratory, Immunology & Infection Cluster, NUI Galway) as a Postdoctoral Researcher. Thus following a transition, my current clinical research focuses on the use of parasite-designed molecules for the treatment of sepsis and its commonest complication, AKI.